
Janux Therapeutics (JANX) had the highest return in February 2024 by a small-cap US stock, returning 456.1%.
| ASSET | MONTH | % RETURN |
|---|---|---|
Janux Therapeutics (JANX) | February 2024 | 456.09% |
SoundHound AI (SOUN) | February 2024 | 336.47% |
Root (ROOT) | February 2024 | 290.16% |
Monopar Therapeutics (MNPR) | February 2024 | 147.02% |
Gaotu Techedu Inc DRC (GOTU) | February 2024 | 132.74% |
GeneDx (WGS) | February 2024 | 111.69% |
Jumia Technologies (JMIA) | February 2024 | 108.56% |
CleanSpark (CLSK) | February 2024 | 106.42% |
Taysha Gene Therapies (TSHA) | February 2024 | 104.53% |
BigBearai (BBAI) | February 2024 | 103.64% |
Ocular Therapeutix (OCUL) | February 2024 | 103.23% |
Larimar Therapeutics (LRMR) | February 2024 | 102.11% |
Trevi Therapeutics (TRVI) | February 2024 | 100% |
Sana Biotechnology (SANA) | February 2024 | 82.88% |
C4 Therapeutics (CCCC) | February 2024 | 74.56% |
Hyliion (HYLN) | February 2024 | 73.33% |
Spire Global (SPIR) | February 2024 | 73.18% |
Entera Bio (ENTX) | February 2024 | 69.75% |
PepGen (PEPG) | February 2024 | 68.82% |
Inovio Pharmaceuticals (INO) | February 2024 | 63.17% |
4D Molecular Therapeutics (FDMT) | February 2024 | 61.97% |
MediaAlpha (MAX) | February 2024 | 61.23% |
Surrozen (SRZN) | February 2024 | 60.49% |
CytomX Therapeutics (CTMX) | February 2024 | 60.13% |
Stoke Therapeutics (STOK) | February 2024 | 59.59% |
Small-cap stocks are treated as having a market cap between $300M and $2B.